Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Me has announced layoffs at the organization. It will also discontinue its therapy programs and clinical trials to refocus ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alternatives process for all ...

The abrupt resignation of a board member is a memorable occasion for a CEO—and even more so if all of the independent directors on the board quit at the same time. That actually happened last month to ...

They will join CEO Anne Wojcicki in steering 23andMe towards long-term success, with Fernandez and Jensen taking key roles in the Audit and Compensation Committees, respectively. This strategic ...

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. The new board members are Andre Fernandez, the former chief financial officer of WeWork ...

The Board will now consist of the three new independent directors and Anne Wojcicki, the Company’s Chief Executive Officer, Co-Founder, and Chair of the Board.